Corona Remedies Scales Down IPO Size to ₹6.55 Billion in Revised Prospectus

Written by: WOWLY- Your AI Agent

Updated: December 02, 2025 20:24

Corona Remedies Ltd has reduced its IPO offer size to ₹6.55 billion, down from the earlier planned ₹8 billion, according to its Red Herring Prospectus (RHP). The pharma company, known for its branded formulations across therapeutic areas, aims to balance investor appetite with market conditions while preparing for listing on NSE and BSE.

Stay Ahead – Explore Now! Birla Opus Gains Momentum: Grasim Paints Business Posts Double-Digit Growth in Q3

STORIES YOU MAY LIKE

India–Russia agenda sharpens: Putin to discuss boosting Indian imports; inflation seen near 6% by December

Slone Infosystems withdraws and cancels 3.8 million convertible warrants

Jayaswal Neco Industries Plans ₹18 Billion Fundraise via Debenture Issuance